Overview
The illegal drug trade in Israel comprises the import, export, manufacture, distribution, and consumption of controlled substances that are prohibited under Israeli law. The market involves a mixture of international trafficking networks, domestic criminal groups, and occasional state‑linked actors. Law‑enforcement agencies, notably the Israel Police, the Israel Security Agency (Shin Bet), and the Ministry of Public Security’s National Authority for the War on Drugs, work together to combat the trade.
Historical development
- 1970s–1990s: Initial growth centered on the smuggling of cannabis (hashish) from the Middle East and North Africa into Israel’s urban centers. In the 1980s, heroin began to appear, largely trafficked through Cyprus and Turkey.
- 1990s–2000s: The emergence of synthetic pharmaceuticals (e.g., MDMA/Ecstasy) and the rise of domestic methamphetamine (“catalina”) labs expanded the range of substances. Israeli authorities reported a gradual shift from pure marijuana consumption toward a more diversified drug market.
- 2010s–present: Increased seizure of cocaine, fentanyl precursors, and novel psychoactive substances (NPS) reflects tighter links with Latin‑American, European, and Asian trafficking routes. Domestic production of synthetic cannabinoids and high‑potency cannabis concentrates has also risen.
Primary substances
| Substance | Source / Production | Typical trafficking route |
|---|---|---|
| Cannabis (hashish, dried flower) | Imported from Morocco, Lebanon, Egypt; growing domestic cultivation | Maritime routes across the Mediterranean; overland via Jordan/West Bank |
| Cocaine | International – primarily from South America (Colombia, Peru) | Transshipped through European hubs, then via air cargo or private couriers to Israeli airports |
| MDMA/Ecstasy | Imported from European manufacturers; some local synthesis | Air freight, parcel services |
| Methamphetamine (including “catalina”) | Domestic clandestine labs; occasional import from Asia | Overland smuggling via Jordan/Arabian Peninsula; small air shipments |
| Fentanyl and analogues | Imported precursors (China, India) for local synthesis | Postal and courier services |
Trafficking routes and mechanisms
- Maritime: Small speedboats and larger commercial vessels dock at Israeli ports (e.g., Haifa, Ashdod) and offshore sites to offload cargo hidden among legitimate goods.
- Air: Parcel services and passenger luggage at Ben Gurion International Airport have been used for high‑value, low‑volume shipments (e.g., cocaine, synthetic drugs).
- Overland: Ground routes through the Jordanian border and the West Bank are employed for cannabis and precursor chemicals.
- Underground tunnels: Limited reports indicate use of tunnels linked to Gaza for small quantities of hashish and hashish resin.
Legal framework
- Dangerous Drugs Ordinance (1973) and subsequent amendments define prohibited substances, penalties, and enforcement powers.
- Penalties: Possession of personal‑use quantities may result in imprisonment (typically up to 1 year) and fines, whereas trafficking, manufacturing, or large‑scale import/export can carry sentences of 5–20 years, with possible asset seizure.
- Regulatory bodies: The National Authority for the War on Drugs (established 2005) coordinates inter‑agency efforts, public‑education campaigns, and treatment programs.
Enforcement and statistics
- Seizures: According to annual reports from the Israel Police, confiscated quantities have risen from ~150 kg of cannabis in 2010 to >500 kg in 2022, while cocaine seizures increased from ~2 kg to >30 kg in the same period.
- Arrests: In fiscal year 2021–2022, the police recorded approximately 6,800 drug‑related arrests, a modest increase over the previous year.
- Drug consumption: Surveys by the Israel Ministry of Health indicate that cannabis remains the most commonly used illicit drug (~12 % of adults reporting use in the past year), with MDMA, cocaine, and amphetamines each used by <2 % of the adult population.
Notable cases and operations
- Operation “Blue Heart” (2015): A joint police‑Shin Bet raid disrupted a network importing MDMA from Belgium, resulting in 17 arrests and seizure of 4 kg of the drug.
- “Meth‑Lab Bust” (2018): Police dismantled a clandestine methamphetamine lab in the Tel Aviv metropolitan area, confiscating 12 kg of precursor chemicals and arresting four individuals.
- “Cocaine Corridor” investigation (2020‑2021): International cooperation with Europol and the U.S. DEA led to multiple arrests linked to a syndicate moving cocaine from South America through Europe to Israel.
International cooperation
Israel participates in several multilateral initiatives:
- EUROPOL & INTERPOL joint task forces targeting synthetic drug networks.
- U.S.–Israel Counter‑Narcotics Partnership, focusing on intelligence sharing and interdiction of fentanyl precursors.
- Regional cooperation with Jordan and Egypt for border‑security enhancements.
Challenges and current trends
- Synthetic drug proliferation: Rapid emergence of NPS complicates classification and enforcement.
- Online marketplaces: Use of encrypted messaging apps and darknet platforms for distribution has increased anonymity.
- Medical cannabis regulation: The 2019 legalization of medical cannabis creates a regulatory environment that authorities must carefully distinguish from illicit activity.
Public health response
- Treatment: The Ministry of Health funds over 50 addiction‑treatment centers nationwide, offering methadone maintenance, counseling, and harm‑reduction services.
- Prevention: Nationwide school‑based education programs, media campaigns (“Say No”), and community outreach aim to reduce demand, particularly among youths.
Summary
The illegal drug trade in Israel is a multi‑faceted phenomenon that includes traditional cannabis smuggling, growing imports of cocaine and synthetic drugs, and domestic production of methamphetamine and novel psychoactive substances. While law‑enforcement agencies have made notable interdictions and have established a comprehensive legal framework, evolving trafficking methods—especially digital platforms and synthetic drug chemistry—present ongoing challenges for both public safety and public health sectors.
